Integration of Genomic Technologies in Clinical Practice:Development of Standard Controls and Best P

来源 :2007年生物芯片与疾病分子分型国际研讨会(International Symposium on Biochip Tec | 被引量 : 0次 | 上传用户:pennate
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Although personalized medicine is being practiced today,increased access to genomic information is transforming the drug and diagnostics development process and giving life to the vision of integrating molecular,genetic and clinical information to improve healthcare.Research and development efforts focused on using microarray technology to identify and measure the genetic information associated with complex disease are evolving into clinical studies and trials geared toward development of new tools for the clinic.
其他文献
目的:观察生地、山茱萸效应成分对体外AGEs生成与清除的影响.方法:加入葡萄糖(终浓度为200mmol/L)和牛血清白蛋白(终浓度40g/L),37℃温孵2周后于530nm处测定早期糖化蛋白(果糖胺);37℃温孵4周后于激发波长360nm,发射波长460nm处测定AGEs的荧光度值(F),建立体外AGEs生成模型;加入葡萄糖(终浓度为200mmol/L)和牛血清白蛋白(终浓度40g/L)后37℃温
会议
会议
The Pharmaceutical industry - and patients - have greatly benefited from the rapid science and technological advances of the last two decades.The Human Genome Project has been a landmark achievement i
会议
会议
会议